CRH and anemia (phenotype): Ramirez reported that the treatment of anemia in dialysis patients with recombinant human erythropoietin hormone could affect the pituitary-hypothalamic-adrenal axis and increase responses of adrenocorticotropin hormone to corticotropin-releasing hormone.